BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11706071)

  • 21. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
    Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
    Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
    Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of positive and negative regulators of cell cycle during wound healing.
    Zhu X; Di Y; Hu C; Wang Z
    Chin Med J (Engl); 2002 Mar; 115(3):326-30. PubMed ID: 11940356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome.
    Sáez A; Sánchez E; Sánchez-Beato M; Cruz MA; Chacón I; Muñoz E; Camacho FI; Martínez-Montero JC; Mollejo M; García JF; Piris MA
    Br J Cancer; 1999 Jul; 80(9):1427-34. PubMed ID: 10424746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.
    Sánchez-Beato M; Sáez AI; Navas IC; Algara P; Sol Mateo M; Villuendas R; Camacho F; Sánchez-Aguilera A; Sánchez E; Piris MA
    Am J Pathol; 2001 Jul; 159(1):205-13. PubMed ID: 11438467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB
    Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas.
    Knopp S; Bjørge T; Nesland JM; Tropé C; Scheistrøen M; Holm R
    Gynecol Oncol; 2004 Oct; 95(1):37-45. PubMed ID: 15385108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.
    Sánchez-Beato M; Sáez AI; Martínez-Montero JC; Sol Mateo M; Sánchez-Verde L; Villuendas R; Troncone G; Piris MA
    Am J Pathol; 1997 Jul; 151(1):151-60. PubMed ID: 9212741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
    Bachmann IM; Straume O; Akslen LA
    Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma.
    Seki R; Okamura T; Koga H; Yakushiji K; Hashiguchi M; Yoshimoto K; Ogata H; Imamura R; Nakashima Y; Kage M; Ueno T; Sata M
    Am J Hematol; 2003 Aug; 73(4):230-5. PubMed ID: 12879424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins.
    Peschos D; Tsanou E; Stefanou D; Damala C; Vougiouklakis T; Mitselou A; Agnantis NJ
    In Vivo; 2004; 18(6):719-24. PubMed ID: 15646812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the expression of cell cycle regulators and microsatellite instability in colorectal carcinomas].
    Yan X; Liu F; Fang D
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):141-4. PubMed ID: 11776643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel.
    Arber N; Hibshoosh H; Yasui W; Neugut AI; Hibshoosh A; Yao Y; Sgambato A; Yamamoto H; Shapira I; Rosenman D; Fabian I; Weinstein IB; Tahara E; Holt PR
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1101-5. PubMed ID: 10613343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.